Results 171 to 180 of about 2,560 (200)

Eligibility for Photoimmunotherapy in Patients With Unresectable Advanced or Recurrent Head and Neck Cancer and Changes Before and After Systemic Therapy

open access: yesCancers, 2023
Photoimmunotherapy is a novel cancer treatment that recently became covered by national health insurance in Japan, but treatment decision-making remains challenging for unresectable advanced or recurrent head and neck cancer.
Takeshi Shinozaki   +2 more
exaly   +2 more sources

Multifunctional Inorganic Nanomaterials for Cancer Photoimmunotherapy [PDF]

open access: yesCancer Communications, 2022
Abstract Phototherapy and immunotherapy in combination is regarded as the ideal therapeutic modality to treat both primary and metastatic tumors. Immunotherapy uses different immunological approaches to stimulate the immune system to identify tumor cells for targeted elimination.
Yijun Mei, Wei Wang, Lu Tang
exaly   +4 more sources

Hurdles for the Wide Implementation of Photoimmunotherapy

Immunotherapy, 2021
Near infrared photoimmunotherapy (NIR-PIT) is a molecularly targeted treatment for cancers achieved by injecting a conjugate of IRDye700DX® (IR700), a water-soluble silicon phthalocyanine derivative in the near infrared, and a monoclonal antibody that targets cancer cell antigens.
Kohei Matsuoka   +2 more
openaire   +2 more sources

Photoimmunotherapy for Cancer Treatment

Journal of Environmental Pathology, Toxicology and Oncology, 2006
Phototherapy, with its effective dose control and light delivery, has become a promising modality for treating malignant and nonmalignant diseases. Photochemical interaction, specifically photodynamic therapy (PDT), and photothermal interaction have been the primary mechanisms for direct cell destruction in the treatment of cancers. Preclinical studies
Wei R, Chen   +4 more
openaire   +2 more sources

Importance of photophosphatidylserine and Tim-3 in photoimmunotherapy

RSC Medicinal Chemistry, 2022
Natural killer (NK) cells help regulate autoimmune reactions, but overactivation causes harm.
Akshansh Sharma   +3 more
openaire   +2 more sources

Near Infrared Photoimmunotherapy for Cancer

Conference on Lasers and Electro-Optics, 2019
Near infrared photoimmunotherapy (NIR-PIT) is a molecularly-targeted cancer photo-therapy based on antibody-photoabsorber (IR700) conjugates. By crashing cancer cells combined with innate and/or adjuvant immune-activation, NIR-PIT activates anti-cancer immunity resulted in curing local and metastatic cancers.
openaire   +2 more sources

Nanomedicine and Biomaterial Platforms for Photoimmunotherapy

Angewandte Chemie
ABSTRACT Photoimmunotherapy, an innovative cancer treatment strategy that integrates photodynamic/photothermal therapy with immune modulation, has achieved significant advances in recent years. Currently, nanomedicine and biomaterial designs in photoimmunotherapy have evolved from simple drug carriers to intelligent systems ...
Chenya Wang, Zhuang Liu
openaire   +2 more sources

Photoimmunotherapy of human uveal melanoma cells

Experimental Eye Research, 1995
To examine whether tumor-reactive monoclonal antibodies can be used to enhance photodestruction of human uveal melanoma cells, we conjugated photosensitizer chlorin e6 monoethylenediamine monoamide (CMA) with a melanoma-reactive monoclonal antibody IG12 and evaluated the effectiveness of this immunoconjugate (IC) in the destruction of OCM431 human ...
L K, Hu   +3 more
openaire   +2 more sources

Photoimmunotherapy in nasopharyngeal carcinoma recurrence.

Journal of Clinical Oncology
6068 Background: Photoimmunotherapy is a novel anticancer treatment developed by the NCI and has been covered by insurance in Japan since January 2021 for patients with unresectable, locally advanced or locally recurrent head and neck cancers. Over 400 patients have been treated with photoimmunotherapy in Japan, including 19 cases with recurrent ...
Takeshi Shinozaki   +17 more
openaire   +1 more source

Home - About - Disclaimer - Privacy